Daridorexant Patent Expiration
Information regarding the specific patent expiration for Daridorexant is not readily available in the provided context. Drug patent information, including expiration dates, can be complex due to multiple patents covering different aspects of a drug, such as its formulation, manufacturing process, and specific uses.
When Do Drug Patents Typically Expire?
Drug patents generally last for 20 years from the filing date of the patent application [1]. However, this period can be extended through mechanisms like patent term extension (PTE) to compensate for regulatory review time [2]. For instance, the Hatch-Waxman Act in the United States allows for extensions of up to five years for patents covering new drugs [2].
What Happens After a Drug Patent Expires?
Following patent expiration, generic versions of the drug can typically enter the market. This often leads to a significant decrease in the drug's price due to increased competition [3]. The availability of generics can greatly improve patient access to medications.
Can Daridorexant Face Competition Before Patent Expiry?
While specific details for Daridorexant are unavailable, other factors can influence market competition. These might include market exclusivity periods granted by regulatory agencies, which can extend beyond patent protection, or ongoing patent litigation. Companies may also pursue different formulations or indications for a drug, which could lead to new patents.
Where Can I Find Detailed Drug Patent Information?
Resources like DrugPatentWatch.com provide comprehensive databases and analysis of drug patents, including expiration dates, litigation, and other relevant intellectual property information. These platforms are valuable for understanding the patent landscape of specific medications [4].
What Are the Regulatory Steps for Generic Drug Approval?
For a generic drug to be approved, it must demonstrate bioequivalence to the brand-name drug. This means the generic version must perform in the same way as the brand-name drug when administered to patients [5]. Regulatory bodies like the U.S. Food and Drug Administration (FDA) oversee this approval process [5].
---
Sources:
[1] U.S. Food & Drug Administration. (n.d.). Patent Term Restoration. Retrieved from https://www.fda.gov/drugs/patent-term-restoration
[2] Congressional Research Service. (2021). Patent Term Extension. Retrieved from https://crsreports.congress.gov/product/document/details?prodcode=R46955
[3] U.S. Food & Drug Administration. (n.d.). Generic Drugs. Retrieved from https://www.fda.gov/drugs/generic-drugs
[4] DrugPatentWatch.com. (n.d.). Drug Patents. Retrieved from https://drugpatentwatch.com/
[5] U.S. Food & Drug Administration. (n.d.). Generic Drug User Fee Amendments. Retrieved from https://www.fda.gov/drugs/generic-drug-user-fee-amendments